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Abstract
Background: High fat diets have long been associated with weight gain and obesity, and the weak satiety response 
elicited in response to dietary lipids is likely to play a role. Suppression of appetite and food intake has consistently 
been shown to be diminished with high fat relative to either high protein or carbohydrate meals. There is however 
some evidence that the satiating capacity of lipids may be modulated when physicochemical properties are altered, 
but studies investigating the effect of lipid saturation on appetite have generated inconsistent findings. This study 
investigated the effects of changes in fatty acid saturation on post-ingestive satiety and energy intake.
Methods: High-fat (HF) test breakfasts (2.0 MJ) containing 26 g lipid were given to 18 healthy, lean men in a 3 
treatment randomised cross-over design, each treatment separated by a washout of at least 3 days. The breakfasts 
were high in saturated (SFA, 65% of total fat), polyunsaturated (PUFA, 76%) or monounsaturated (MUFA, 76%) fatty 
acids, and comprised 2 savoury muffins. Participants rated appetite sensations using visual analogue scales (VAS) to 
assess palatability immediately following the meals, and hunger and fullness prior to the HF breakfast and throughout 
the day. Energy intake was measured by covert weighing of a lunch meal which was served 3.5 h after the breakfast, 
and from which the participants ate ad libitum.
Results: There was no difference in VAS ratings of pleasantness, visual appearance, smell, taste, aftertaste and overall 
palatability between the 3 high-fat test breakfasts. However, there was also no differential effect of the 3 treatments on 
ratings of hunger, fullness, satisfaction or prospective food consumption during the 3.5 h following the breakfast meal 
and over the full 6 h experiment. Energy and macronutrient intake at lunch also did not differ between treatments 
(mean, sem; SFA: 5275.9 ± 286.5 kJ; PUFA: 5227.7 ± 403.9 kJ; MUFA: 5215.6 ± 329.5 kJ; P > 0.05). The maximum difference 
in energy intake between treatments was less than 2%.
Conclusions: There was no evidence of a difference in post-ingestion satiety between high fat meals which differed in 
saturation profile in this group of lean, healthy men.
Trial Registration: ACTRN12610000193077
Introduction
A high intake of dietary fat has long been implicated in
the development of obesity with a positive association
between a high-fat (HF), high-energy dense diet and a
high body mass index (BMI) [1,2]. Whether there is a
causal relationship between dietary fat and the current
high levels of obesity continues to be debated however,
[3-8] as does dietary fat as a primary driver of hyper-
phagia, or overconsumption, during weight gain. In a
number of early studies dietary fat was shown to exert a
weaker satiating effect than isoenergetic amounts of
either carbohydrate (CHO) or protein in most [9-11],
although not all [12,13] studies. Possibly factors such as
palatability [14], high energy density [10,11,15-17] and
relatively weak oxidative feedback of dietary lipids [15,18-
20] may play a role in overconsumption of lipid-rich
* Correspondence: s.poppitt@auckland.ac.nz
6 Human Nutrition Unit, School of Biological Sciences & Department of 
Medicine, University of Auckland, Auckland, New Zealand
Full list of author information is available at the end of the articleStrik et al. Nutrition Journal 2010, 9:24
http://www.nutritionj.com/content/9/1/24
Page 2 of 12
foods [10], the latter hypothesis having been recently
revisited [21]. The inability of lipids to mount a strong
postprandial satiety-related hormone response relative to
the other macronutrients may also contribute [17,22,23].
There is also some evidence to suggest that the associa-
tion of a HF diet with weight gain and obesity may in part
depend on the saturation of the fatty acids (FA) con-
sumed and that unsaturated, and in particular polyunsat-
urated FAs (PUFA), may be associated with lower
adiposity [24-26]. Several studies have shown that the
rate of postprandial fat oxidation, purported to act as a
satiety feedback signal, is negatively related to the degree
of saturation [27-33]. In early studies degree of saturation
was also linked with changes in putative appetite modifi-
ers such as CCK [34], insulin and serotonin [35]. In addi-
tion, effects on ad libitum energy intake (EI) have been
reported. Whilst there is some evidence of PUFA having
the strongest and MUFA the weakest suppression of food
intake, clinical studies are inconsistent and variable. A
gastrointestinal infusion study showed high-PUFA
Intralipid® (a fat emulsion comprising largely soybean oil)
and linoleic acid (18:2) to decrease intake when com-
pared with a no-fat saline control, whilst carbon chain
length (CCL) -matched stearic acid (C18:0, SFA) and
oleic acid (C18:1, MUFA) did not [36]. In a feeding study
of CCL-matched fats, both high-PUFA and high-SFA
meals decreased food intake when compared with high-
MUFA meals [37], and a second infusion study showed
lauric acid (C12:0 SFA) but not the longer chain oleic acid
(C18:1 MUFA) to decrease food intake relative to a saline
control [38]. Conversely, other studies have found less
convincing [39,40] or no evidence of saturation affecting
ad libitum EI or appetite ratings [41-43], or with response
differing by gender [39].
This lack of consensus led to our current study which
investigated whether changes in the saturation profile of a
high-fat breakfast meal affected postprandial appetite
sensations and food consumption at the subsequent meal
using a study design which we have previously shown to
be sensitive to manipulations in energy and fat content
[44]. Based on prior studies we hypothesized that there
may be a satiety hierarchy of PUFA > SFA > MUFA when
a high fat meal balanced for both energy and total fat con-
tent is consumed.
Participants and Methods
Participants
Lean male participants (BMI 18-25 kg/m2), aged between
18-55 years were recruited into this intervention trial
through poster, newspaper and electronic advertisement.
Body weight and height were measured whilst fasted on 2
consecutive occasions and mean BMI recorded. Partici-
pants were from the local community including tertiary
institutions. Exclusion criteria were self-reported current
or previous history of overweight or obesity, current or
recent history (previous 6 months) of dieting including
commercial weight loss programs or weight loss surgery,
eating disorders or significant restraint [45], smoking,
hypertension, cardiovascular disease, diabetes mellitus
(type I or II), and any significant metabolic, endocrine or
gastrointestinal disease. Normal lipid profile, full blood
count and fasting blood glucose levels were also ensured
at screen. None of the participants were taking medica-
tions known to affect appetite or weight regulation. Writ-
ten consent was obtained from each of the participants.
Ethical approval for this study was obtained from the
Northern Regional Ethics Committee, Auckland, New
Zealand.
Experimental design
This was a randomised, 3 treatment cross-over trial
where the effects of a HF test breakfast supplemented
with SFA, PUFA or MUFA were assessed through subjec-
tive visual analogue scales (VAS) and ad libitum EI at a
single lunch meal. The primary objective of measurement
of food intake at the lunch meal was not revealed to the
participants prior to the study. All participants attended
the Human Nutrition Unit (HNU) on three separate
occasions between which they returned home for a wash-
out period of at least 3 days where they were asked to
resume their habitual diet and exercise pattern. Partici-
pants were asked to abstain from alcohol and strenuous
physical activity for 24 hours prior to the study-day, and
to complete a 24-hour dietary recall and physical activity
questionnaires. Physical activity was estimated using a
questionnaire evaluating activities according to duration
and intensity using the PEPSA (Physical Exercise Pro-
gramme for Sedentary Adults) points system [46] to
assess whether differences in activity on the day prior to
the test may have confounded measured outcomes of
appetite.
Participants were asked to fast from 2000 h the previ-
ous evening, including liquids, not to exercise in the
morning and to arrive at the Unit using motorized trans-
port. At the clinic body weight and waist circumference
were measured fasted, and adverse events and/or medica-
tions used between treatments recorded. Immediately
upon arrival at 7 am the participants were given 200 ml
water which they were required to drink in full, after
which they were asked to complete baseline VAS rating
their subjective feelings of hunger, fullness, satisfaction
and prospective food consumption [47]. A venous can-
nula was also inserted for sequential collection of blood
samples throughout the morning, and lipid profile, glu-
cose and insulin concentrations were measured. The HF
test breakfast was served at 0830 h and participants were
asked to consume the test-meal in full but at their own
pace within a 15 minute period. The exact duration of theStrik et al. Nutrition Journal 2010, 9:24
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meal was recorded. No further foods were allowed
throughout the morning until an ad lib lunch meal was
served 210 minutes later, at 1200 h, to assess energy and
macronutrient intake. Lunch was served individually in a
quiet dining room with minimal distractions. VAS ratings
were measured throughout the morning and for 2 hours
after completion of the ad lib lunch. All measurements of
food intake were covert. Participants remained at the
HNU during each study-day and were allowed to read,
write or undertake other such sedentary activities but
were not allowed to sleep.
High-fat test breakfasts
The 3 breakfast treatments were HF (50 en% fat) and
isoenergetic (2.0 MJ), comprising 2 savoury muffins
(ingredients: flour, skimmed milk powder, eggs, tomato,
ham, test lipid). The lipids were included as an integral
part of the recipe and baked into the muffins. The test
breakfast was served at 0830 h, co-presented with 300 ml
water. The treatments differed in FA composition and
were (i) high-SFA (from butter fat), (ii) high-PUFA (from
safflower oil) or (iii) high-MUFA (from olive oil). The
energy and macronutrient composition of the 3 test
breakfasts was calculated using the dietary program
FoodWorks™ (Professional Edition, Version 2.10.136,
1998-2000; Xyris Software) and are shown in Table 1.
Visual Analogue Scales
Participants rated their hunger, fullness, satisfaction and
prospective consumption (how much do you think you
could eat now?) using VAS [47]. Subjective feelings were
recorded by placing a vertical line across 100 mm scales,
anchored at either end by statements; "I am not hungry at
all/I am not full at all/I am completely empty/Nothing at
all" on the left and "I am as hungry I have ever been/I am
totally full/I cannot eat another bite/A large amount" on
the right. VAS rating how thirsty, energetic and relaxed
the participants felt were included as a distraction from
the main outcome. VAS were completed prior to the test
meal and 15, 30, 45, 60, 90, 120, 150, 180, 210, [ad lib
lunch], 270, 330 and 390 minutes after the participant
began consumption of the test breakfast. Immediately
after breakfast, participants also rated the pleasantness,
visual appeal, smell, taste, aftertaste and overall palatabil-
ity of the breakfast using separate 100-mm VAS [9,47].
These questions were anchored on the left by each of the
statements "not at all pleasant/bad visual appeal/bad
smell/bad taste/strong aftertaste/bad palatability" and on
the right by the statements "as pleasant as I have ever
tasted/good visual appeal/good smell/good taste/no
aftertaste/good palatability".
Ad libitum lunch
The ad libitum lunch consisted of a restricted buffet-style
meal with predominantly cold and one hot meal choice,
along with a selection of beverages. In an attempt to avoid
over-consumption the variation of meal items offered was
limited. Participants were advised that they could eat as
much or as little as they chose and that they were to
remain in the room for a period of 45 minutes. The items
presented at the ad lib buffet meal, along with their serv-
ing weight, energy and macronutrient content are shown
in Table 2. All discrete items (eg bread) were presented as
small portions (e.g. quarter slices of bread), and all items
were served in excess. Covert weighing of each meal item
was carried out before and after lunch to allow calcula-
tion of energy and macronutrient intake. Food items were
weighed to the nearest 0.5 g (Sartorius AG, Goettingen,
Germany), and energy and macronutrient content of
foods consumed calculated using the dietary program
FoodWorks (Professional Edition Version 2.10.136 1998-
2000; Xyris Software).
Statistical Analysis
VAS data were analysed using a repeated measures Linear
Mixed Model ANOVA (SAS: PROC MIXED, SAS version
8.0, SAS Institute Inc, Cary, NC, 2001). The participant,
the dietary treatment, the intervention period, and the
study day were included in the procedure, as was the
treatment/time interaction which addressed whether the
trajectory over time during the intervention period dif-
fered between treatments (diet*time). MANOVA was
also used to generate a full model for VAS incorporating
all dependent variables. Energy and macronutrient intake
data from the ad lib lunch meal was analysed using uni-
variate ANOVA (SAS: PROC MIXED, SAS version 8.0,
SAS Institute Inc, Cary, NC, 2001). Univariate ANOVA
was also used to determine any differences in EI or physi-
cal activity level on the day prior to each treatment visit
(Day-1). The trial was analysed on the basis of intention
to treat (ITT), hence all data from all treatment visits
completed were included in the analysis. Missing data
was assumed missing at random and no data imputation
was performed. Statistical significance was based on 95%
limits (P < 0.05). Participant characteristics are presented
as m ean,  s tanda r d devia t io n (m ean,  S D) .  Effica cy e nd-
points are presented as mean, standard error of the mean
(mean, SEM).
Results
Participants
Eighteen (18) male participants were randomized into the
study, of which 17 completed all 3 treatments. One par-
ticipant completed only 2 treatments (SFA, MUFA; PUFA
treatment was not completed) due to relocation overseas,
hence a total of 53 of the scheduled 54 study visits were
completed. Participant characteristics are shown in Table
3. They were on average young, lean men. All participants
were normoglycaemic with no evidence of hyperlipidae-Strik et al. Nutrition Journal 2010, 9:24
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mia or hypertension. On the day prior to intervention
there was no significant difference in reported EI (mean,
SEM) between treatments (SFA: 8338, 738 kJ/day; PUFA:
8259, 640 kJ/day; MUFA: 7919, 790 kJ/day; treatment, P >
0.05) or reported level of physical activity (treatment, P >
0.05). Physical activity level (mean, SEM) was assessed
through hours spent on mild-moderate activity (SFA: 2.1,
0.4 h; PUFA: 2.4, 0.4 h; MUFA: 2.8, 0.6 h), minutes spent
on vigorous-strenuous activity (SFA: 4.2, 2.9 m; PUFA:
8.8, 5.6 m; MUFA:10.8, 5.7 m), hours standing (SFA: 4.1,
0.7 h; PUFA: 3.4, 0.5 h; MUFA: 4.0, 0.6 h), hours sitting
and watching TV/video (SFA: 4.5, 0.9 h; PUFA: 5.1, 0.8 h;
MUFA: 4.2, 0.9 h), and total PEPSA points (SFA:16.9, 4.3;
PUFA: 21.2, 6.5; MUFA: 28.1, 10.2). Between participants
results were highly variable and there were no significant
treatment effects (treatment, P > 0.05).
Visual Analogue Scales
There was no difference in VAS ratings of pleasantness,
visual appearance, smell, taste, aftertaste and overall pal-
atability between the 3 HF test breakfasts when assessed
immediately following consumption (treatment, P > 0.05,
Figure 1), indicating that participants were unable to dif-
ferentiate between the saturation profiles using visual and
sensory cues in this blinded trial. VAS were also used to
assess subjective feelings of hunger and satiety through-
out the experiment. Figure 2 shows the mean ratings for
hunger, fullness, satisfaction and prospective food con-
sumption during the 6 hours following the test breakfast
for each of the high-SFA, high-PUFA and high-MUFA
treatments. As expected following a 2MJ meal, hunger
and prospective consumption significantly decreased and
fullness and satisfaction significantly increased immedi-
ately following each of the treatments, and then gradually
returned to baseline by 210 mins (time, P < 0.01). Con-
sumption of the ad lib lunch also induced significant
changes in V AS-rated measures of appetite and satiety
during the afternoon. There was however no significant
difference in mean ratings of hunger, fullness, satisfaction
Table 1: Energy and macronutrient composition of the 3 high-fat breakfast test meals
High-SFA (Butter fat) High-PUFA (Safflower oil) High-MUFA (Olive oil)
Weight, as eaten (g) 151 151 145
Energy (kJ) 1974 1952 1955
Energy density (kJ/g) 13.1 12.9 13.4
Total Fat (g) 26.5 25.9 26.1
Protein (g) 15.9 15.7 15.7
CHO (g) 41.9 41.7 41.8
C12:0 0.8 0 0
C14:0 2.7 0 0
C16:0 6.8 1.8 2.9
C18:0 3.4 0.7 0.8
other 3.4 0.1 0.2
ΣSFA 17.1 2.6 3.8
C18:2n6 2.1 19.7 2.4
C18:3n3 0.2 0.1 0.2
ΣPUFA 2.2 19.8 2.5
C18:1 6.4 3.7 19.5
other 0.7 0 0.2
ΣMUFA 7.1 3.7 19.8
kJ from Fat (%) 50.0 49.4 49.4
kJ from Protein (%) 13.9 13.7 13.7
kJ from CHO (%) 34.3 34.2 34.2
Fat as SFA (%) 64.8 10.0 14.6
Fat as PUFA (%) 8.4 75.7 9.6
Fat as MUFA (%) 26.7 14.2 75.8
SFA, saturated fatty acids; PUFA, polyunsaturated fatty acids; MUFA, monounsaturated fatty acids; CHO, carbohydrateStrik et al. Nutrition Journal 2010, 9:24
http://www.nutritionj.com/content/9/1/24
Page 5 of 12
or prospective consumption between the 3 treatments
when measured over the 3.5 hours between the test
breakfast and ad lib lunch meal (0-210 mins; all, treat-
ment*time P > 0.05) or when measured throughout the
full study day (0-390 mins; all, treatment*time P > 0.05).
The use of MANOVA to combine VAS measurements for
all treatments was also unable to identify a significant dif-
ference between treatments either before lunch or over
the full study day (treatment*time, P > 0.05). Analysis of
the sequential blood collects also showed there to be no
difference between circulating levels of serum choles-
terol, triacylglycerol (TAG), glucose or insulin between
the SFA, MUFA and PUFA treatments (all, treat-
ment*time P > 0.05).
Energy and macronutrient intake at the ad libitum lunch
Mean total EI and energy contributed by CHO, fat and
protein respectively at the ad lib lunch is presented for
each treatment in Figure 3. There was no significant dif-
ference in total EI between lipid treatments (treatment, P
> 0.05). Mean (SEM) EI at lunch was 5275.9 (286.5) kJ,
5227.7 (403.9) kJ, and 5215.6 (329.5) kJ following the SFA-
, PUFA-, and MUFA-rich breakfasts respectively. The
maximum difference between treatments was less than
2%. When macronutrient intake was compared between
treatments there was no significant difference in CHO,
fat or protein nor weight of food consumed at the lunch
meal (treatment, P > 0.05).
Discussion
There was no evidence from this study that changes made
to the fatty acid saturation of a high fat breakfast altered
subjective hunger ratings or energy intake at the subse-
quent lunch meal in a group of healthy male participants.
This is consistent with a number [41-43] but not all [36-
38,40] previously published studies, and there are several
issues concerning study design which it is important to
consider.
There are a wide range of published methods by which
short-term appetite regulation has been assessed but
consensus is yet to be achieved as to best practice [48].
The methodology in our current trial was based primarily
on the lipid emulsion trials of Burns and colleagues [49-
51] where small manipulations in lipids at a test breakfast
induced significant changes in EI at a subsequent lunch
meal. Arguably, the long separation between the inter-
vention and the ad lib lunch (>3 hours) in these trials may
make changes in eating behaviour more difficult to effect
than studies where an outcome meal is given only 60 or
90 minutes following the test treatment. In our current
Table 2: Energy content and macronutrient composition of foods offered to participants at the ad libitum lunch meal
Menu Items Portion Size (g) No. of typical serves Energy (kJ) Protein (g) Fat (g) CHO (g)
Main meal items
Fried rice 1600 8 4621 39.0 29.8 167.4
Bread, light rye, quarter slices 168 2 1781 13.3 3.2 62.0
Bread, white, quarter slices 168 2 1814 13.6 3.2 83.8
Chicken breast, flesh, roasted, shredded 190 8 1170 48.1 9.8 0
Smoked ham slices, chopped 190 8 888 30.4 3.8 13.3
Capsicum red & green, raw 68 1 72 0.9 0.2 3.0
Tomatoes, raw 127 1 86 20.0 0.3 3.4
Spiced apple and fruit loaf, quarter slices 400 10 5620 20.0 45.2 212.4
Peach slices, tinned in fruit juice, drained 820 4 1476 4.1 0.8 77.9
Condiments
Butter 250 50 6457 2.5 175.0 3.5
Mayonnaise 250 10 3675 2.0 76.8 44.5
Soy sauce 300 10 297 3.0 0 15.0
Drinks
Cola drink 1500 10 2943 0 0 178.2
Orange juice 1000 5 1027 2.1 3.1 52.9
Milk, full fat (for decaffein- ated tea/coffee) 1000 20 2550 31.0 33.0 47.0
Water, bottled 1500 10 0 0 0 0
CHO, carbohydrateStrik et al. Nutrition Journal 2010, 9:24
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trial however the ad lib energy intake was consistent with
the recorded postprandial feelings of hunger and fullness
which also did not differ across lipid treatments. It is pos-
sible that the varied item buffet-style lunch may have
encouraged overconsumption, decreased sensitivity and
masked differential effects, but again it is notable that a
multi-item buffet lunch has previously been shown to be
sensitive to effects of acute lipid manipulations [49-51].
We have previously shown it to be sensitive to changes in
energy content at a breakfast meal [44]. Pleasantness,
visual appeal, smell, taste, after-taste and palatability were
all well matched between treatments in our current trial,
and differences in the energy density of the test lipids
were small.
There is little consensus as to whether degree of lipid
saturation may play a role in regulation of body weight
and adiposity through mechanisms driving changes in
either intake or oxidation. Whilst epidemiological evi-
dence of an association between lipid saturation and adi-
posity in studies such as the Quebec Family Study [24]
suggest that saturation may influence either intake or oxi-
dation, evidence remains scant. Friedman originally pro-
posed the hypothesis that oxidation of macronutrients
following a meal may exert a negative feedback on appe-
tite and eating behavior, and hence control the satiating
power of a given nutrient [18]. Whilst human studies
have been unable confirm this mechanism [17], there are
some data which do show an oxidative gradient may exist
and may be driven in part by FA saturation [25,27-33] and
hence the hypothesis remains of interest [21]. Interest-
ingly, FA saturation has also been shown to impact post-
prandial hormone response including the peptides
insulin [52] and CCK [34,36] which may drive changes in
intake, although again the data remains inconclusive [53-
55].
Much of the evidence for effect of saturation on EI has
b e e n  d e r i v e d  f r o m  a c u t e  s t u d i e s  o f  i n t a k e  o f  s i m i l a r
design to our current trial and also from acute GI infu-
sion trials, several of which show increased satiety effects
of PUFA. Intestinal infusion of Intralipid (54% PUFA
linoleic acid, 29% MUFA oleic acid) and PUFA (linoleic
acid), but not SFA (stearic acid) or MUFA (oleic acid)
emulsions tended to decrease EI relative to a saline con-
trol in a study of men given a restricted lunch meal [36].
The effects were modest however with no significant dif-
ferential effects between the 4 fat loaded treatments. This
was supported in part by Lawton et al (2000) in a CCL-
matched feeding study which demonstrated decreased
ratings of appetite and a trend, albeit non-significant,
towards lower ad lib EI over the rest of the day following
a high-PUFA (linoleic acid) and SFA (stearic-oleic blend)
lunch meal compared with a lunch rich in MUFA (oleic
acid) [37]. A second study by the same authors was
unable to confirm these results, although merging data
from the 2 studies did support the greater satiety effects
of PUFA [37]. A more recent intraduodenal infusion
study of the C12:0 SFA lauric acid versus longer chain
C18:1 MUFA oleic acid showed a decrease in EI following
the SFA but not MUFA treatment relative to a saline con-
trol [38]. Conversely, there are also studies which find
MUFA to be more satiating than PUFA [39,40]. For exam-
ple, Burton-Freeman et al (2005) found that mean VAS
Table 3: Participant characteristics at baseline. 
Baseline Mean SD
n 18
Age (y) 27.8 8.0
Body weight (kg) 69.3 6.4
BMI (kg/m2)2 2 . 0 1 . 9
Waist circumference (cm) 75.2 3.9
TC (mmol/L) 4.2 0.7
LDL-C (mmol/L) 2.2 0.5
HDL-C (mmol/L) 1.6 0.3
TAG (mmol/L) 0.9 0.4
TC:HDL-C ratio 2.7 0.5
Glucose (mmol/L) 4.5 0.3
SBP (mm Hg) 108 13
DBP (mm Hg) 64 8
All measurements made at screen visit.  Mean (SD). BMI, body mass index; TC, total cholesterol; LDL-C, low density lipoprotein cholesterol; 
HDL-C, high density lipoprotein cholesterol; TAG, triacylglycerol; SBP, systolic blood pressure; DBP, diastolic blood pressureStrik et al. Nutrition Journal 2010, 9:24
http://www.nutritionj.com/content/9/1/24
Page 7 of 12
Figure 1 There was no difference between mean (SEM) VAS ratings of pleasantness, visual appeal, smell, taste, aftertaste or palatability 
between the 3 test-breakfasts when assessed immediately after the meal (treatment, P > 0.05). SFA, high-saturated fatty acids (n = 18); PUFA, 
high-polyunsaturated fatty acids (n = 17), MUFA, high-monounsaturated fatty acids (n = 18).
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scores of appetite satisfaction were greater following a
high-oleic safflower oil (high-MUFA) compared with a
walnut oil (high-PUFA) preload, although it is notable
that this result was not substantiated by 4 other appetite-
related VAS or subsequent ad lib EI at lunch [39]. Finally
there are further trials which are consistent with our cur-
rent study and which have been unable to detect a differ-
ence in ratings of appetite or EI between meals of varying
saturation profile [41-43]. It is apparent that a clear effect
of lipid saturation on satiety has yet to be established.
Some variability in outcome may in part be due to dif-
ferences in methods. Important aspects of trials assessing
postprandial changes in appetite may include number
and characteristics of participants; lipid dose, composi-
tion and route of administration; inter-meal interval; and
composition and variety of foods offered at the ad lib out-
come meal. These have been summarized in Table 4. Of
the trials so far conducted, all were small sample studies
(8-25 participants) conducted predominantly in lean,
healthy participants. Dose of lipid administered does not
appear to unduly bias outcome since studies by Lawton
[37] and Flint [42] both administered high doses of lipid
(>50 g fat), yet only the Lawton study conducted in lean
participants showed differential effects of FA saturation.
The fact that delivery of lower doses, such as our current
trial (26 g), are sufficient to elicit a response was demon-
strated by Kamphuis and colleagues where a 25 g lipid
supplement differentially altered EI [40]. Burton-Free-
man [39] administered a low dose (9-13 g) lipid treatment
yet observed significant effects on some VAS-assessed
Figure 2 Mean (SEM) VAS for hunger, fullness, satisfaction and prospective consumption between 0-390 minutes. Each high lipid test break-
fast was given immediately after the baseline (t = 0 mins) VAS, and the ad libitum lunch was served at 210 minutes. SFA, high-saturated fatty acids (n 
= 18); PUFA, high-polyunsaturated fatty acids (n = 17), MUFA, high-monounsaturated fatty acids (n = 18).Strik et al. Nutrition Journal 2010, 9:24
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satiety ratings, albeit these did not result in suppression
of EI at a subsequent test meal. The route of lipid admin-
istration is likely to also be important and it is notable
that 2 [38,56] of the 4 [37,40] trials where a differential
response was elicited delivered the lipid treatments via GI
infusion hence bypassing early sensory and cognitive sig-
naling. Whilst it is difficult to find methodological issues
directly responsible for the variable outcome of the stud-
Figure 3 Mean (SEM) energy intake at the ad libitum lunch meal, showing the macronutrient components consumed. SFA, high-saturated 
fatty acids (n = 18); PUFA, high-polyunsaturated fatty acids (n = 17), MUFA, high-monounsaturated fatty acids (n = 18).
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Table 4: Previous studies investigating the effect of fatty acid saturation on subjective appetite ratings and ad libitum energy intake (measured or from diet records) 
at a meal, highlighting methodological differences between trials
Publication Participants Lipid dose Lipid composition [% of total 
lipid]
Inter-meal 
interval
Study endpoint Study outcome
Current study: Strik et al., 
2010
Lean, men, n = 18 26 g, [50 en% fat] Butter fat, high stearic-lauric blend 
[65% SFA]; Olive oil, high oleic acid 
[76% MUFA]; Safflower oil, linoleic 
acid [76% PUFA]
210 mins Ad libitum EI from lunch 
meal
No effect of saturation on EI
Lawton et al., 2000 [37] Lean, men, n = 10 
women, n = 10
Women 58 g; Men 83 g; 
[55 en% fat]
Stearic-oleic blend [44% SFA, 44% 
MUFA]; High-oleic oil [81% MUFA]; 
High linoleic oil [75% PUFA]
240 mins Ad libitum EI from buffet 
dinner + snack boxes
PUFA and SFA tended to 
decrease EI relative to MUFA 
(trend only)
French et al.,2000 [36] Lean, men, n = 10 Duodenal infusion; 20 g 
lipid emulsion [100 en% 
fat], at rate of 1 mL/min 
over 100 mins
High stearic/oleic [40% SFA; 44% 
MUFA]; High oleic acid [75% MUFA]; 
High linoleic acid [74% PUFA]; 
Intralipid [16% SFA, 29% MUFA, 54% 
PUFA]; saline
90 mins Ad libitum EI from lunch 
meal
PUFA decreased EI relative 
to SFA and MUFA (trend 
only); signif lower than 
saline control
Kamphuis et al., 2001 [40] Overweight, men, 
n = 8; women, n = 8
20 ml (~20 g) lunch; 25 ml 
(~25 g) dinner added to 
usual diet [~36 en % fat]
High-linoleic oil [67% LA, PUFA]; 
High-γ-linolenic [20% GLA, PUFA]; 
High-oleic oil [80% MUFA]
Test lipids given as 
part of ad lib meals
24-h ad libitum EI: 
restricted choice; lunch, 
dinner, snacks
MUFA decreased EI relative 
to PUFA at test dinner; no 
difference over 24 h
Alfenas et al., 2003 [43] Lean, men, n = 9; 
women, n = 11
30-40 g; [54-59 en % fat] Butter fat [66% SFA]; Peanut oil [49% 
MUFA]; Canola oil [62% MUFA]; fat 
free
>120 mins Diet records of EI during 
free feeding over 24-h [no 
outcome meal]
No effect of saturation on EI
MacIntosh et al., 2003 [41] Lean, men, n = 10 30 g; [55 en% fat] Butter fat [69% SFA]; Sunola oil [80% 
MUFA]; Sunflower oil [64% PUFA];
120 mins Ad libitum EI from lunch 
meal + diet; diet records 
over rest of day
No effect of saturation on EI
Flint et al., 2003 [42] Overweight men, n 
= 19
63-87 g; [60 en% fat] High-oleic sunflower oil [83% 
MUFA]; Hydrogenated rapeseed oil 
[54% trans; 31% SFA]; Grape- seed 
oil [70% PUFA]
300 mins Ad libitum EI from lunch 
meal
No effect of saturation on EI
Burton-Freeman et al., 
2005 [39]
Lean, men, n = 12; 
women, n = 13
Men 13 g; Women 9 g; [39 
en% fat]
High-oleic safflower oil [72% MUFA]; 
Walnut oil [66% PUFA];Ground 
walnuts [66% PUFA]; low fat [1.4 g 
fat]
45 mins Ad libitum EI from lunch 
meal
No effect of saturation on EI
Feltrin et al. 2008 [38] Lean, men, n = 13 Duodenal infusion; ~3 g 
lipid emulsion [100en% 
fat], at rate of 4 mL/min 
over 60 mins
Lauric acid [100% SFA]; Oleic acid 
[100% MUFA]; saline
60 mins Ad libitum EI from lunch 
meal
SFA decreased EI relative to 
MUFA and saline controlStrik et al. Nutrition Journal 2010, 9:24
http://www.nutritionj.com/content/9/1/24
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ies to date, each of the trials appears robust in its
approach, it is clear that a strong case cannot be built for
enhanced satiety with high-SFA, MUFA or PUFA based
on current evidence.
Conclusions
In this study we were unable to show differential changes
in postprandial feelings of hunger or fullness, or changes
in energy intake at a lunch meal when alterations were
made to the fatty acid saturation of a high-fat breakfast.
Lipid dose, the interval between test-breakfast and ad
libitum outcome lunch, and the composition of the ad lib
meal have all been identified as areas which may bias out-
come. In this study we administered a 26 g lipid test meal
which was well matched for sensory outcomes between
treatments, 3.5 hours prior to a free choice lunch meal.
Whether a higher dose lipid product administered as a
preload rather than test meal, i.e. closer to the lunch
meal, would elicit an appetite response is unknown. Cer-
tainly there is little consensus on effects of dietary lipid
composition on appetite control from previous studies.
Whether appetite may be altered by longer term and sus-
tained changes in dietary fatty acid composition also
remains to be demonstrated.
List of abbreviations used
ANOVA: analysis of variance; BMI: body mass index;
CCL: carbon chain length; CCK: cholecystokinin; CHO:
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analysis of variance; MUFA: monounsaturated fatty acid;
PEPSA: Physical Exercise Programme for Sedentary
Adults; PUFA: polyunsaturated fatty acid; SD: standard
deviation; SEM: standard error of the mean; SFA: satu-
rated fatty acid; VAS: visual analogue score.
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